Zacks Research Expects Reduced Earnings for Tenet Healthcare

Tenet Healthcare Co. (NYSE:THC) – Stock analysts at Zacks Research lowered their Q2 2026 EPS estimates for shares of Tenet Healthcare in a report issued on Wednesday, March 26th. Zacks Research analyst R. Department now forecasts that the company will post earnings per share of $3.33 for the quarter, down from their prior estimate of $3.34. The consensus estimate for Tenet Healthcare’s current full-year earnings is $12.24 per share. Zacks Research also issued estimates for Tenet Healthcare’s Q3 2026 earnings at $3.08 EPS.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings data on Wednesday, February 12th. The company reported $3.44 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.95 by $0.49. Tenet Healthcare had a return on equity of 21.88% and a net margin of 15.48%.

A number of other research analysts have also issued reports on THC. Truist Financial decreased their target price on shares of Tenet Healthcare from $190.00 to $175.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Barclays dropped their price objective on Tenet Healthcare from $190.00 to $161.00 and set an “overweight” rating for the company in a report on Thursday, February 13th. StockNews.com raised Tenet Healthcare from a “hold” rating to a “buy” rating in a research note on Thursday, March 13th. TD Cowen began coverage on shares of Tenet Healthcare in a research note on Wednesday, February 26th. They set a “buy” rating and a $175.00 price objective on the stock. Finally, JPMorgan Chase & Co. reaffirmed an “overweight” rating and set a $175.00 price target on shares of Tenet Healthcare in a report on Tuesday, December 17th. Three equities research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $166.41.

Tenet Healthcare Trading Down 0.9 %

Shares of Tenet Healthcare stock opened at $133.17 on Monday. Tenet Healthcare has a 52-week low of $90.03 and a 52-week high of $171.20. The stock has a market cap of $12.67 billion, a PE ratio of 4.13, a PEG ratio of 1.02 and a beta of 2.06. The firm has a 50-day moving average of $132.43 and a 200-day moving average of $142.31. The company has a debt-to-equity ratio of 2.25, a quick ratio of 1.70 and a current ratio of 1.78.

Institutional Investors Weigh In On Tenet Healthcare

A number of institutional investors have recently made changes to their positions in THC. Wealth Enhancement Advisory Services LLC increased its position in Tenet Healthcare by 10.3% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 8,836 shares of the company’s stock valued at $1,115,000 after purchasing an additional 827 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in shares of Tenet Healthcare during the fourth quarter worth $8,783,000. Forum Financial Management LP lifted its holdings in Tenet Healthcare by 43.5% in the fourth quarter. Forum Financial Management LP now owns 2,469 shares of the company’s stock valued at $312,000 after buying an additional 749 shares during the period. Neo Ivy Capital Management bought a new stake in Tenet Healthcare during the fourth quarter valued at $2,773,000. Finally, Vise Technologies Inc. raised its position in shares of Tenet Healthcare by 28.4% in the 4th quarter. Vise Technologies Inc. now owns 1,613 shares of the company’s stock worth $204,000 after acquiring an additional 357 shares in the last quarter. Institutional investors own 95.44% of the company’s stock.

Insiders Place Their Bets

In other news, Director J Robert Kerrey sold 9,525 shares of Tenet Healthcare stock in a transaction on Tuesday, March 11th. The shares were sold at an average price of $125.43, for a total transaction of $1,194,720.75. Following the transaction, the director now owns 27,378 shares in the company, valued at approximately $3,434,022.54. The trade was a 25.81 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.93% of the company’s stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.